Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab

BMC Pulmonary Medicine
Dante A SuffrediniMichael A Solomon

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare cause of pulmonary hypertension that is associated with malignancies and is marked by the presence of non-occlusive tumor emboli and fibrocellular intimal proliferation of small pulmonary arteries leading to increased pulmonary vascular resistance and right heart failure. The diagnosis of PTTM is challenging to make pre-mortem and guidelines on treatment are lacking. A 45-year-old woman with advanced squamous cell carcinoma of the cervix developed symptoms of dyspnea and evidence of right heart failure during a phase I clinical trial with cediranib and durvalumab. After an extensive evaluation, pre-capillary pulmonary hypertension was confirmed by right heart catheterization. Vasodilator therapy was initiated but resulted in the development of symptomatic hypoxemia and was discontinued. Despite continued supportive care, she continued to decline and was transitioned to hospice care. At autopsy, the cause of her right heart failure was found to be due to PTTM with features of pulmonary veno-occlusive disease (PVOD). PTTM and PVOD are important diagnoses to consider in patients with a malignancy and the development of right heart failure and may be manifestations of a sp...Continue Reading

References

Jul 13, 1989·The New England Journal of Medicine·R G MassonJ McGrath
Jul 1, 1982·Clinical Nuclear Medicine·R J BoudreauH Sheldon
Oct 1, 1993·Chest·M R KramerJ Lafair
May 15, 2007·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Aletta Ann FrazierJeffrey R Galvin
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott KopetzJohn V Heymach
Jan 6, 2012·The New England Journal of Medicine·Michael C GavinJoseph Loscalzo
Nov 22, 2012·Seminars in Ultrasound, CT, and MR·Carlos S RestrepoFernando R Gutierrez
Jun 19, 2013·Internal Medicine·Hironori UrugaKazuma Kishi
Aug 3, 2013·The Journal of Clinical Investigation·Jonathan WeltiPeter Carmeliet
Dec 18, 2013·Circulation Research·Peter M GeorgeJane A Mitchell
Jun 17, 2014·American Journal of Respiratory Cell and Molecular Biology·Norbert F Voelkel, Jose Gomez-Arroyo
Jun 22, 2014·Circulation Research·Marlene RabinovitchMark R Nicolls
Dec 17, 2014·The American Journal of Pathology·Benoît RanchouxFrédéric Perros
Jul 25, 2015·The European Respiratory Journal·Neelam KumarS John Wort
Jul 9, 2016·Current Opinion in Pulmonary Medicine·Laura C PriceStephen J Wort
Jun 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tina CasconeJohn V Heymach
Aug 8, 2017·Pulmonary Circulation·Rohit GodboleNader Kamangar
Jan 11, 2018·The New England Journal of Medicine·Michael A PostowMatthew D Hellmann

❮ Previous
Next ❯

Citations

Apr 8, 2020·Pulmonary Circulation·Shraddha NarechaniaGustavo A Heresi

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT02484404

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.